Plus Therapeutics (PSTV) Competitors $0.34 +0.02 (+6.83%) Closing price 04:00 PM EasternExtended Trading$0.33 -0.01 (-3.60%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PSTV vs. APYX, MODD, TELA, COCH, BDMD, DXR, POCI, ECOR, MDAI, and DRIOShould you be buying Plus Therapeutics stock or one of its competitors? The main competitors of Plus Therapeutics include Apyx Medical (APYX), Modular Medical (MODD), TELA Bio (TELA), Envoy Medical (COCH), Baird Medical Investment (BDMD), Daxor (DXR), Precision Optics (POCI), electroCore (ECOR), Spectral AI (MDAI), and DarioHealth (DRIO). These companies are all part of the "medical equipment" industry. Plus Therapeutics vs. Apyx Medical Modular Medical TELA Bio Envoy Medical Baird Medical Investment Daxor Precision Optics electroCore Spectral AI DarioHealth Plus Therapeutics (NASDAQ:PSTV) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, community ranking, profitability, valuation, analyst recommendations, media sentiment and dividends. Does the MarketBeat Community prefer PSTV or APYX? Apyx Medical received 6 more outperform votes than Plus Therapeutics when rated by MarketBeat users. However, 62.61% of users gave Plus Therapeutics an outperform vote while only 60.94% of users gave Apyx Medical an outperform vote. CompanyUnderperformOutperformPlus TherapeuticsOutperform Votes7262.61% Underperform Votes4337.39% Apyx MedicalOutperform Votes7860.94% Underperform Votes5039.06% Which has better earnings and valuation, PSTV or APYX? Plus Therapeutics has higher earnings, but lower revenue than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Plus Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPlus Therapeutics$4.91M1.08-$13.32M-$2.50-0.13Apyx Medical$47.29M1.16-$18.71M-$0.55-2.64 Is PSTV or APYX more profitable? Apyx Medical has a net margin of -58.59% compared to Plus Therapeutics' net margin of -225.07%. Plus Therapeutics' return on equity of 0.00% beat Apyx Medical's return on equity.Company Net Margins Return on Equity Return on Assets Plus Therapeutics-225.07% N/A -154.56% Apyx Medical -58.59%-137.98%-36.74% Do institutionals & insiders have more ownership in PSTV or APYX? 3.3% of Plus Therapeutics shares are owned by institutional investors. Comparatively, 55.3% of Apyx Medical shares are owned by institutional investors. 3.8% of Plus Therapeutics shares are owned by insiders. Comparatively, 16.8% of Apyx Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media prefer PSTV or APYX? In the previous week, Plus Therapeutics had 2 more articles in the media than Apyx Medical. MarketBeat recorded 3 mentions for Plus Therapeutics and 1 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 0.29 beat Plus Therapeutics' score of -0.07 indicating that Apyx Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Plus Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Apyx Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, PSTV or APYX? Plus Therapeutics has a beta of 0.88, meaning that its stock price is 12% less volatile than the S&P 500. Comparatively, Apyx Medical has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500. Do analysts prefer PSTV or APYX? Plus Therapeutics currently has a consensus target price of $11.50, indicating a potential upside of 3,574.12%. Given Plus Therapeutics' higher probable upside, analysts clearly believe Plus Therapeutics is more favorable than Apyx Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Plus Therapeutics 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50Apyx Medical 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.67 SummaryApyx Medical beats Plus Therapeutics on 12 of the 19 factors compared between the two stocks. Get Plus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PSTV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PSTV vs. The Competition Export to ExcelMetricPlus TherapeuticsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.30M$4.54B$5.40B$8.47BDividend YieldN/A43.65%5.22%4.11%P/E Ratio-0.1230.0626.7519.95Price / Sales1.0871.09393.46114.60Price / CashN/A51.0838.2534.62Price / Book-1.046.326.834.58Net Income-$13.32M$68.16M$3.22B$248.19M7 Day Performance-40.95%21.40%5.26%2.14%1 Month Performance-51.17%26.00%13.27%16.20%1 Year Performance-85.31%22.32%17.58%7.87% Plus Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PSTVPlus Therapeutics1.3784 of 5 stars$0.34+6.8%$11.50+3,290.3%-85.4%$5.77M$4.91M-0.1320Gap DownAPYXApyx Medical0.7688 of 5 stars$1.11-4.7%N/A-6.9%$41.76M$48.10M-1.33270Gap UpMODDModular Medical0.8682 of 5 stars$1.02+2.0%N/A-48.1%$41.48MN/A-1.9220Positive NewsGap UpTELATELA Bio1.85 of 5 stars$1.01-6.5%$7.25+617.8%-78.8%$39.95M$69.30M-0.60120COCHEnvoy Medical1.7404 of 5 stars$1.67-1.5%$9.13+448.0%-46.9%$35.51M$212,000.00-1.2134BDMDBaird Medical InvestmentN/A$5.35+3.3%N/AN/A$35.22M$33.05M0.00N/ADXRDaxor3.8148 of 5 stars$7.26-6.3%$25.00+244.4%-21.5%$35.12M$2.13M0.0037Gap UpPOCIPrecision Optics0.6709 of 5 stars$4.58-1.1%N/A-32.6%$35.11M$18.68M-7.1680Earnings ReportGap DownHigh Trading VolumeECORelectroCore2.9359 of 5 stars$4.82+3.7%$25.50+429.0%-24.0%$34.67M$25.18M-2.6350Positive NewsHigh Trading VolumeMDAISpectral AI2.9053 of 5 stars$1.36+9.7%$4.75+249.3%-26.1%$34.43M$29.58M-2.0983Analyst RevisionDRIODarioHealth1.6745 of 5 stars$0.76+1.3%$1.50+97.4%-60.8%$31.59M$27.04M-0.81200News CoverageEarnings ReportAnalyst Forecast Related Companies and Tools Related Companies Apyx Medical Competitors Modular Medical Competitors TELA Bio Competitors Envoy Medical Competitors Baird Medical Investment Competitors Daxor Competitors Precision Optics Competitors electroCore Competitors Spectral AI Competitors DarioHealth Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PSTV) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Plus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Plus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PSTV Stock Free PSTV Stock Alerts